Translational success of fundamental virology: a VSV-vectored Ebola vaccine

被引：3

作者：

Anderson, Elizabeth M. ^{[1
]}

Coller, Beth-Ann G. ^{[1
]}

机构：

[1] Merck & Co Inc, Rahway, NJ 07065 USA

来源：

JOURNAL OF VIROLOGY | 2024年 / 98卷 / 03期

基金：

美国国家卫生研究院; 英国惠康基金;

关键词：

Ebola; vaccine development; partnership; innovation; VSV-vector; rVSV Delta G-ZEBOV-GP; ZEBOV-GP VACCINE; VESICULAR STOMATITIS VIRUSES; PROTECTS NONHUMAN-PRIMATES; RESEARCH-AND-DEVELOPMENT; SIERRA-LEONE TRIAL; IMMUNIZATION PRACTICES; MEDIATED PROTECTION; ADVISORY-COMMITTEE; CLINICAL-RESEARCH; MARBURG VIRUS;

D O I：

10.1128/jvi.01627-23

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Ebola virus disease (EVD) caused by Ebola virus (EBOV) is a severe, often fatal, hemorrhagic disease. A critical component of the public health response to curb EVD epidemics is the use of a replication-competent, recombinant vesicular stomatitis virus (rVSV)-vectored Ebola vaccine, rVSV Delta G-ZEBOV-GP (ERVEBO). In this Gem, we will discuss the past and ongoing development of rVSV Delta G-ZEBOV-GP, highlighting the importance of basic science and the strength of public-private partnerships to translate fundamental virology into a licensed VSV-vectored Ebola vaccine.

引用

页数：8

共 50 条

[1] Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
Santoro, Francesco
Donato, Alessia
Lucchesi, Simone
Sorgi, Sara
Gerlini, Alice
Haks, Marielle C.
Ottenhoff, Tom H. M.
Gonzalez-Dias, Patricia
Nakaya, Helder, I
Huttner, Angela
Siegrist, Claire-Anne
Medaglini, Donata
Pozzi, Gianni
VACCINES, 2021, 9 (02) : 1 - 15
[2] Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine
Wong, Gary
MBIO, 2019, 10 (04):
[3] Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo
Steven P. Toniolo
Sam Afkhami
Michael R. D’Agostino
Brian D. Lichty
Emily D. Cranston
Zhou Xing
Michael R. Thompson
Scientific Reports, 10
[4] Molecular Mechanism of VSV-Vectored ASFV Vaccine Activating Immune Response in DCs
Ma, Yunyun
Shao, Junjun
Liu, Wei
Gao, Shandian
Zhou, Guangqing
Qi, Xuefeng
Chang, Huiyun
VETERINARY SCIENCES, 2025, 12 (01)
[5] Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo
Toniolo, Steven P.
Afkhami, Sam
D'Agostino, Michael R.
Lichty, Brian D.
Cranston, Emily D.
Xing, Zhou
Thompson, Michael R.
SCIENTIFIC REPORTS, 2020, 10 (01)
[6] A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever
Cross, Robert W.
Woolsey, Courtney
Prasad, Abhishek N.
Borisevich, Viktoriya
Agans, Krystle N.
Deer, Daniel J.
Geisbert, Joan B.
Dobias, Natalie S.
Fenton, Karla A.
Geisbert, Thomas W.
CELL REPORTS, 2022, 40 (03):
[7] A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
Foster, Stephanie L.
Woolsey, Courtney
Borisevich, Viktoriya
Agans, Krystle N.
Prasad, Abhishek N.
Deer, Daniel J.
Geisbert, Joan B.
Dobias, Natalie S.
Fenton, Karla A.
Cross, Robert W.
Geisbert, Thomas W.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (12)
[8] Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization
Dan Shan
Xiaoyan Tang
Renqiang Liu
Dan Pan
Xijun Wang
Jinying Ge
Zhiyuan Wen
Zhigao Bu
Virologica Sinica, 2022, 37 (02) : 248 - 255
[9] Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization
Dan Shan
Xiaoyan Tang
Renqiang Liu
Dan Pan
Xijun Wang
Jinying Ge
Zhiyuan Wen
Zhigao Bu
Virologica Sinica, 2022, (02) : 248 - 255
[10] Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization
Shan, Dan
Tang, Xiaoyan
Liu, Renqiang
Pan, Dan
Wang, Xijun
Ge, Jinying
Wen, Zhiyuan
Bu, Zhigao
VIROLOGICA SINICA, 2022, 37 (02) : 248 - 255

← 1 2 3 4 5 →